| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.089 | 0.03 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.094 | 0.03 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |